Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism pantetheinase inhibitors(vanin 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H22N6O2 |
InChIKeyVGRLXWFIXGZRMS-UHFFFAOYSA-N |
CAS Registry2173134-00-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | US | 17 Jan 2022 |